Regenerative medicine and stem cells are often uttered within the same breath, for good reason.
In animal models, stem cells have reliably reversed brain damage from Parkinsons disease, repaired severed spinal cords, or restored damaged tissue from diabetes, stroke, blood cancers, heart disease, or aging-related tissue damage. With the discovery of induced pluripotent stem cells (iPSCs), in which skin and other tissue can be reversed into a stem cell-like state, the cells have further been adapted into bio-ink for 3D printing brand new organs.
Yet stem cells are hard to procure, manufacture, and grow. And unless theyre made from the patients own cell supplymassively upping production coststheyre at risk of immune rejection or turning cancerous inside their new hosts.
Thinking outside the stem cell box, two teams have now explored alternative paths towards repairing damaged tissue, both inside and outside the body. The first, published in Nature, found that a tiny genetic drug fully restored heart function in a pig after an experimental heart attack.
Pig hearts are remarkably similar to human hearts in size, structure, and physiology, to the point that they may eventually become candidates for pig-to-human xenotransplants. Although itll take some time before we can proceed to clinical trials, said lead author Dr. Mauro Giacca from Kings College London, the drugthe first of its kindis a promising move towards repairing heart damage directly inside patients.
The second study, outlined in Nature Communications, explores a radically different approach that restores damaged lungs, which can then be used for tissue transplantation. To address the pressing need for donor lungs, Dr. Matt Bachetta at Vanderbilt University and colleagues from Columbia University developed a new protocol that not only keeps donor pig lungs alive, but also repairs any damage sustained during the extraction process so that the organs meet every single criterion for transplantation.
Video Credit: Brandon Guenthart/Columbia Engineering
Both ideas are universal in that they can potentially be expanded to other organs. Unlike stem cell treatments, theyre also one size fits all in that the therapies will likely benefit most patients without individual tailoring.
To be clear, Giaccas new treatment isnt gene therapy, in that it doesnt fundamentally change a hearts genetic code.
Rather, it relies on weird little RNA fragments called microRNAs. Similar to RNA, which carries genetic code from DNA to our cells protein-making factories, these molecules are made up of four genetic letters and flow freely inside a cell.
Averaging just 22 letters, microRNAs powerfully control gene expression in that they can shut down a gene without changing its genetic code. Scientists dont yet fully understand how microRNAs work. But humans have up to 600 different types of these regulators floating around our cells, and theyve been linked to everything from cancer and kidney problems to brain development, transgenerational inheritanceand yesheart disease.
These mysterious genetic drugs could meet a critical clinical need. Although modern medicine has ways to reduce damage from heart attacks, surviving patients still often retain permanent damage to the hearts structure, Giacca explained. Unlike skin or liver cells, mature heart cells are stoic little buggers in that they dont usually replenish themselves. This causes the heart to lose its ability to properly contract and pump blood, which eventually leads to heart failure.
Giaccas team decided to see if they could kick mature heart cells back into dividing action, rather than forming scar tissue. Using a high-volume screen, they first looked through miRNAs that can stimulate mature heart cells to divide after a heart attack in mice. One promising candidate emerged: hsa-miRNA-199a-3p (yeah, catchy, I know).
Next, the team used a virus to deliver the microRNA candidate into the hearts of 25 pigs, which were subjected to an experimental heart attack that blocked blood flow to the heart for 90 minutes. The miRNA, restricted to only the heart, immediately worked its magic and shut down several genetic pathways. Although the heart still retained damage, measured two days following the heart attack, within a month it reduced scar tissue by 50 percent. The treated hearts were also far stronger in their ability to contract compared to non-treated hearts, and grew slightly in muscle size.
Under the microscope, the team found that the miRNA forced mature heart cells back into a younger state. The cells regained their ability to divide and supplement damaged tissue. Its not an easy surgery: the team directly jabbed the heart 20 times with the virus to ensure that the organ evenly received the genetic drug.
The therapy also comes with a potentially troubling consequence. The team followed 10 pigs after the one-month mark. Although their heart functions readily improved, seven suddenly died from heart tremors within three to four weeks without any warning. Subsequent detective work revealed that it could be due to overgrowth of new heart cells. The treatment needs careful dosing, they concluded.
Despite these hiccups, the miRNA therapy is a welcome new addition to the heart regeneration family. It is a very exciting moment for the field. After so many unsuccessful attempts at regenerating the heart using stem cells, which all have failed so far, for the first time we see real cardiac repair in a large animal, said Giacca.
Bacchettas lung recovery team took a different approach. Rather than trying to directly repair lungs inside the body, they tackled another clinical problem: the lack of transplantable donor lungs.
Roughly 80 percent of donor lungs are too damaged for transplantation, said Bacchetta. Although there are many sources of trauma, including injuries from ventilators or fluid buildup inside the organ, the team focused on a major cause of damage: stomach contents.
Lungs are sensitive snowflakes. Theyre extremely easily scuffed up by stuff that comes out of our stomachs, such as food particles, bile, gastric juices, and enzymes. If youve ever had a horrific hangover over the toiletwell, you know it burns. Usually our lungs can heal; but in the case of transplantationright after deaththey often dont have the time to self-repair.
This lung shortage led Bacchettas team to look for alternative ideas. We were searching for a way to extend the ability to provide life-saving therapy to patients, he said, a search that took seven years of banging their heads against a wall.
Then came the winning lightbulb moment: if man-made devices arent enough to repair lungs outside the body, what about the eventual recipient? After all, lungs dont work alonethey thrive in a physiological milieu chock full of molecules that activate when the body senses injury.
I decided, look, weve got to use the whole body. The only way to do that was to use the potential donor recipient essentially as a bioreactor, said Bacchetta.
The team first poured gastric acid into the lungs of an unconscious donor pig to mimic injury. After six hours, they extracted the damaged lung and placed it carefully into a warm, humidified sterile bowlthe organ chamberand hooked the organ up to a ventilator. They then connected the lungs blood vessels to the recipients circulation. This essentially uses the recipient to help break down toxic molecules in the injured lungs while supplying them with fresh nutrients and healing factors.
It sounds pretty gruesome, but the trick worked. When supplemented with a wash that rinsed out stomach juices, the lungs regenerated in just three days. Compared to non-treated lungs, their functions improved six-fold. The technique restored and maintained the function of donor lungs for up to 36 hours, but Bacchetta expects to further expand the window to days or even weeks.
Our work has established a new benchmark in organ recovery, said Bacchetta. It has opened up new pathways for translational applications and basic science exploration.
Neither study is perfect, but they represent new pathways into regenerative medicine outside stem cells. And when it comes to saving lives, its never good to put all eggs inside one (stem cell) basket, especially when the need is large, pressing, and unmet.
Image Credit: sciencepics / Shutterstock.com
Read more here:
New Progress in Stem-Cell-Free Regenerative Medicine
- Blinatumomab Instead of Chemo in Young Patients With Relapsed ALL - Medscape - December 10th, 2019
- Fate Therapeutics Soars as Much as 45.8% After Giving Investors What They Wanted - The Motley Fool - December 10th, 2019
- FDA Warns Liveyon Over Cord Blood Stem Cell Products - MedPage Today - December 10th, 2019
- Gamida Cell Announces Results from Phase 1 Study of GDA-201 and New Mechanism of Action Data at ASH 2019 Annual Meeting - Business Wire - December 10th, 2019
- AgeX Therapeutics Issues Year-End Letter to Shareholders - BioSpace - December 10th, 2019
- Jasper Therapeutics Announces Upcoming Data Presentation on Lead Program, JSP191, at 61st American Society of Hematology (ASH) Annual Meeting &... - December 10th, 2019
- The Uncertainty of Regulating 3D Organ Printing - The Regulatory Review - December 10th, 2019
- Top Florida Medical Spa, Amnion of Florida, Partners With Merakris Therapeutics to Advance Their Non-Surgical Treatment Options - Business Wire - December 10th, 2019
- Mustang Bio Announces Updated Clinical Data on MB-107 Lentiviral Gene Therapy for Patients with X-Linked Severe Combined Immunodeficiency -... - December 10th, 2019
- Orchard Therapeutics Showcases Clinical Data at the 61st American Society of Hematology Annual Meeting - BioSpace - December 10th, 2019
- MacroGenics Presents Flotetuzumab Data in Patients with Primary Induction Failure and Early Relapsed Acute Myeloid Leukemia at the 2019 ASH Annual... - December 10th, 2019
- Olympic Hall of Fame Inductee Gary Hall Jr. Joins C3 International Board of Advisors - BioSpace - December 10th, 2019
- Celgene Gave This Tech Back to Editas Medicine, but It Could Prove Valuable - The Motley Fool - December 8th, 2019
- Jasper Therapeutics Raises $35M in Series A Financing - FinSMEs - December 8th, 2019
- Addressing Disparities in Cancer: Factors Influencing Care, Access and Outcomes - OncoZine - December 8th, 2019
- Interview: Shaping the future - The Actuary - December 5th, 2019
- Cobalt Chloride Induced Apoptosis by Inhibiting GPC3 Expression via th | OTT - Dove Medical Press - December 5th, 2019
- First UK Clinical Trial Site Open for Recruitment of Diabetic Patients with Chronic Limb-Threatening Ischemia Using Novel Patient-Specific... - December 5th, 2019
- Medicine Against Bone Disease Found in the Leaves of Saussurea - Global Health News Wire - December 5th, 2019
- Will We Live to Age 120? International Expert Weighs in at Danbury Event - HamletHub - December 5th, 2019
- Study highlights the need to adhere to more uniform diagnostic criteria for rare lymphoma - News-Medical.net - December 5th, 2019
- 100 hospitals and health systems with great orthopedic programs | 2019 - Becker's Hospital Review - December 5th, 2019
- Investigating the Human Intestinal Mucus Barrier Up-close and Personal - Technology Networks - December 5th, 2019
- Stem cells do help restore heart function but in a different way - News-Medical.net - November 30th, 2019
- Medicine of the future: cell technologies in Ukraine - Interfax-Ukraine - November 30th, 2019
- Stem Cell Therapy May Improve Heart Health In New Ways - TheHealthMania - November 30th, 2019
- Stem Cells & Medicine A Closer Look at Stem Cells - November 28th, 2019
- Intermountain to open new center for pediatric precision medicine - Healthcare IT News - November 28th, 2019
- Stem Cells Doctors | Regenerative Medicine | Stem Cell ... - November 28th, 2019
- Regenerative Medicine Market size with global investment, top companies analysis, new business developments and forecast 2025 - WindStreetz - November 28th, 2019
- Homology Medicines Announces Peer-Reviewed Publication Demonstrating its AAVHSC Vectors Crossed the Blood-Brain-Barrier and Blood-Nerve-Barrier in... - November 28th, 2019
- Discover The Latest Frontier in Anti-aging Medicine and 3 Regenerative Therapies You Should Know... - YourObserver.com - November 28th, 2019
- Worldwide Markets for Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing, Forecast to 2030 - Robust Pipeline of Therapy Candidates and... - November 28th, 2019
- FDA-approved drug to prevent organ rejection may slow skin aging - News-Medical.net - November 25th, 2019
- Health & Biotech: Mesoblast still not in the black, but theyre less in the red than last year - Stockhead - November 25th, 2019
- Regenerative Medicine Market: Rising Government Investments in Regenerative Medicine Research - The Chicago Sentinel - November 25th, 2019
- Visiongain Report Offers Transformative Insights on the $3.2bn Protein Expression Market - PRNewswire - November 25th, 2019
- Research Antibodies and Reagents Market Worth $14.56 Billion by 2025 - Exclusive Report by Meticulous Research - GlobeNewswire - November 25th, 2019
- Immune-Onc Therapeutics Prepares for its Next Phase of Growth with New Leadership Appointments and Key Board Member Additions - Business Wire - November 25th, 2019
- Breakthrough Discovery In Plants DNA May Lead To Slowing Aging Process In Humans - CBS Pittsburgh - November 24th, 2019
- Missing Link To Longevity Discovered In The Plant Kingdom - Texas A&M University - November 24th, 2019
- Multiple Doses of Stem Cells Show Potential in Treating Severe Asthma - PR Web - November 21st, 2019
- Full Alliance Group Announces New EBO2 Sites in Florida and the Caribbean - P&T Community - November 21st, 2019
- Vor Biopharma and MaxCyte Announce Clinical and Commercial License Agreement for Engineered Hematopoietic Stem Cells (eHSCs) to Treat Cancer | More... - November 21st, 2019
- Global Cell Separation Market 2020-2024 | Evolving Opportunities with Akadeum Life Sciences and Becton, Dickinson and Co. | Technavio - Business Wire - November 21st, 2019
- Not happy with smaller paper (letter) | Letters To The Editor - LancasterOnline - November 21st, 2019
- Growing at an Annualized Rate of Over 20%, The Cell Therapy Manufacturing Market is Estimated to Reach Close to USD 10 Billion by 2030, Claims Roots... - November 21st, 2019
- WCM-Q explores law and ethics of stem cells and AI in medicine - Gulf Times - November 17th, 2019
- Global Regenerative Medicine Market to Grow Over $81 Billion by 2023 and Market Driven by Stem Cells - PharmiWeb.com - November 17th, 2019
- New Invention of Artificial intelligence in Medicine with Stem Cells by WCM-Q - Universal News - November 17th, 2019
- Introducing the Targeted Anticancer Therapies and Precision Medicine in Cancer Collection - PLoS Blogs - November 17th, 2019
- Regenerative Medicine Market 2017, Trend, CAGR Status, Key Players, Industry Analysis and Forecast by 2023 - Markets Gazette 24 - November 17th, 2019
- How in utero Zika virus infection can lead to microcephaly in newborns: Baylor research - Outbreak News Today - November 17th, 2019
- The Global Trend to Trash Regulations and Rush Drugs to Market - PsychCentral.com - November 16th, 2019
- Stem Cell And Regenerative Therapy Market to witness a healthy growth by 2024 - Guru Online News - November 16th, 2019
- Stem Cell Umbilical Cord Blood (UCB) Market 2019: Growth Factors, Applications, Regional Analysis, Key Players and Forecast by 2025 |Advanced Cell... - November 16th, 2019
- Works complete on ground-breaking medical research centre at University of Nottingham - East Midlands Business Link - November 16th, 2019
- ISSCA Faculty Honored with Health Sciences Awards at Conference Held at the University of Miami - PRUnderground - November 12th, 2019
- BrainStorm Cell Therapeutics Announces Ralph Kern MD MHSc to Present at the 7th International Stem Cell Meeting - GlobeNewswire - November 12th, 2019
- Learn How You Can Treat Your Pain with Regenerative Medicine! - Patch.com - November 12th, 2019
- New Drug Benefits Patients With Myeloma Who Are Resistant to All Therapies - Dana-Farber Cancer Institute - November 12th, 2019
- Notice of Business Alliance between Promethera Biosciences SA and MEDIPAL HOLDINGS - Business Wire - November 12th, 2019
- Silencing Of MAGI1 Promotes The Proliferation And Inhibits Apoptosis O | OTT - Dove Medical Press - November 12th, 2019
- Stem Cell Banking Market 2019: Growth, Trends, Demand, Share, Analysis and Forecast to 2026 - Markets Gazette 24 - November 12th, 2019
- 4th Annual Bioprocessing of Advanced Cellular Therapies & Regenerative Medicine Congress - Montana Ledger - November 12th, 2019
- Global Progenitor Cell-Based Market to Witness Robust Expansion throughout the Forecast 2026 - Herald Correspondent - November 11th, 2019
- Business Analytics of Regenerative Medicine Market to See Excellent Growth by 2026 |Popular Keysights: Organogenesis Inc., Vericel Corporation, Osiris... - November 11th, 2019
- Analysis of Regenerative Medicine Market 2019-2024: Industry Trends, Share, Size, Price, Revenue, Business Strategy, Production Technology Forecast to... - November 11th, 2019
- Sangamo Announces Gene Therapy and Ex Vivo Gene-Edited Cell Therapy Data Presentations at the American Society of Hematology Annual Meeting - Yahoo... - November 10th, 2019
- Beyond the genome: RNA control of stem cells - Science Magazine - November 8th, 2019
- The final frontier? Studying stem cells on the International Space Station - Scope - November 8th, 2019
- Space travel affects heart cells, but only temporarily - BBC Focus Magazine - November 8th, 2019
- Super-grafts That Could Treat Diabetes - Technology Networks - November 8th, 2019
- Sangamo Therapeutics (SGMO) Announces Gene Therapy and Ex Vivo Gene-Edited Cell Therapy Data Presentations at ASH - StreetInsider.com - November 8th, 2019
- Doheny and UCLA Stein Eye Institutes Welcome Kaustabh Ghosh, PhD, to the Scientific and Clinical Research Faculty - P&T Community - November 3rd, 2019
- Neural Stem Cell Transplantation Crawls Toward the Clinic - The Scientist - October 31st, 2019
- Exosome Procedures Now Being Included With the R3 Stem Cell Regenerative Aesthetics Training Course - Yahoo Finance - October 31st, 2019
- New NCCN Guidelines Debut to Manage Complications and Improve Readiness for Stem Cell Transplant Recipients - P&T Community - October 31st, 2019
- Briggs undergrad researcher wins award at international conference - MSUToday - October 31st, 2019
- Delivering the promise of regenerative medicine - PMLiVE - October 31st, 2019